PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
54.58
ESG score 90-95% of SGMO's 58.56. Bill Ackman would demand clear ESG improvement catalysts.
49.62
Environmental score 80-90% of SGMO's 55.43. Walter Schloss would scrutinize carbon exposure and transition planning.
57.51
Social score 90-95% of SGMO's 61.34. Bill Ackman would demand clear social improvement catalysts.
56.60
Similar governance score to SGMO's 58.92. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.